C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance
| Autor: | Cristina Procopio, Michele Paganelli, Lucia Perego, Simona Frontoni, Marina Cardellini, Franco Folli, Antonio E. Pontiroli, Giorgio Sesti, Maria Adelaide Marini, Monica D’Adamo, Maurizio Giacomelli, Francesco Andreozzi, Renato Lauro, Marta Letizia Hribal |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2005 |
| Předmět: |
Male
Adult medicine.medical_specialty Settore MED/09 - Medicina Interna Genotype Endocrinology Diabetes and Metabolism medicine.medical_treatment Gastric Bypass type 2 diabetes-mellitus genetics sensitivity Polymorphism Single Nucleotide Cohort Studies Promoter Regions Insulin resistance Genetic Polymorphism (computer science) Reference Values Internal medicine Diabetes mellitus Internal Medicine Medicine Humans Obesity Allele Polymorphism Morbid Promoter Regions Genetic Pancreatic hormone Advanced and Specialized Nursing Female Insulin Resistance Obesity Morbid Adipose Tissue Interleukin-6 business.industry Insulin Single Nucleotide medicine.disease Endocrinology Cohort business |
| Popis: | OBJECTIVE—The C-174G promoter polymorphism of the interleukin (IL)-6 gene was found to influence transcriptional activity and plasma IL-6 levels in humans. We addressed the question of whether the C-174G IL-6 polymorphism contributes to variation of insulin sensitivity. RESEARCH DESIGN AND METHODS—Two cohorts of subjects were genotyped. Cohort 1 includes 275 nondiabetic subjects who underwent a euglycemic-hyperinsulinemic clamp. Cohort 2 includes 77 patients with morbid obesity who underwent laparoscopic adjustable gastric banding (LAGB). RESULTS—The genotypes were consistent with Hardy-Weinberg equilibrium proportions. In cohort 1, insulin sensitivity was reduced in carriers of the −174G/G genotype as compared with subjects carrying the C allele (P = 0.004). Carriers of −174G/G displayed significantly higher plasma IL-6 levels in comparison with carriers of the C allele. In a stepwise linear regression analysis, the C-174G polymorphism was independently associated with insulin sensitivity; however, after inclusion of plasma IL-6 concentrations, the polymorphism was excluded from the model explaining insulin sensitivity variability, thus suggesting that the polymorphism was affecting insulin sensitivity by regulating IL-6 plasma levels. IL-6 mRNA levels were measured by real-time RT-PCR in subcutaneous fat obtained from obese patients of cohort 2 during LAGB. Carriers of −174G/G showed increased IL-6 expression compared with subjects carrying the C allele (P = 0.04). There was a significant correlation between adipose IL-6 mRNA expression and insulin resistance assessed by homeostasis model assessment (ρ = 0.28, P = 0.014). CONCLUSIONS—These results indicate that the −174G/G genotype of the IL-6 gene may contribute to variations in insulin sensitivity. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|